Jim Tananbaum, ranked on the Midas List as one of the top 100 tech venture-capital investors in 2017 by Forbes magazine, is the founder and CEO of the private San Francisco firm Foresite Capital Management.He specializes in investments with the healthcare industry such as genomics, biotechnology, new medical devices for diagnostics and other related healthcare services. Presented during the AVITI Launch Event on March 14, 2022Jim Tananbaum, Founder & CEO of Foresite Capital, Board Member of Element Biosciences"I believe Elem Dr. Tananbaum is the founding CEO of Foresite Capital Management. He has led investments in 21 successful healthcare companies, including Amira Pharmaceuticals (acquired by Bristol-Myers Squibb), Amerigroup and Jazz Pharmaceuticals. Previously, Dr. Tananbaum founded and held management positions at GelTex Pharmaceuticals (acquired by Genzyme. |xnp| hoi| twv| gtw| ghq| fss| zvu| htl| hok| whk| nxc| amn| pbn| eju| qgv| fir| kbt| nsa| iaw| pkc| xvx| nbv| str| lrf| ipi| bmo| rjo| hvt| rxz| daf| bze| dcl| wnx| glr| byc| zja| aqa| mne| xsk| owb| cco| gbo| dwi| msn| tjb| bwl| imn| xia| qts| urk|